United States

United States country outline

Estimated Number of Current PrEP Users

220,000-225,000

Aggregate Target Number of PrEP Users from All Projects (Planned and Ongoing)

225,000-230,000

Types of Delivery Projects

  • Clinical trial
  • Demonstration projects
  • Implementation initiative
  • National health system

*Definitions of types of projects available in the glossary below.

Drug Registration Status

  • Gilead’s Truvada (TDF/FTC) is registered and approved for prevention
  • Generic versions of TDF/FTC are approved for prevention

Research, Demonstration and Implementation Projects

Click here for a full list of ongoing and planned research/demonstration projects in United States.

Policy Framework

Funding

NICHD, California HIV/AIDS Research Program, California Collaborative Treatment Group, CDC Foundation, NIAAA, Public Health Foundation Enterprises, Inc., UCLA


Eligibility Criteria
Resources for United States
Glossary of Terms

Last updated August 13, 2018.

News Spotlight